These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26397192)

  • 1. Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC.
    Ding K; Fan L; Chen S; Wang Y; Yu H; Sun Y; Yu J; Wang L; Liu X; Liu Y
    Oncol Rep; 2015 Dec; 34(6):3297-303. PubMed ID: 26397192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells.
    Liu G; Fan X; Tang M; Chen R; Wang H; Jia R; Zhou X; Jing W; Wang H; Yang Y; Yin F; Wei H; Li B; Zhao J
    Cancer Lett; 2016 Dec; 383(2):171-182. PubMed ID: 27702661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
    Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
    Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
    Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
    Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.
    Jiang X; Wang J; Zhang K; Tang S; Ren C; Chen Y
    Med Oncol; 2015 May; 32(5):141. PubMed ID: 25805567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
    Chen RX; Xia YH; Xue TC; Ye SL
    Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein.
    Zhang J; Yamada O; Matsushita Y; Chagan-Yasutan H; Hattori T
    Leuk Res; 2010 Jun; 34(6):763-8. PubMed ID: 19767100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells.
    Im E; Yeo C; Lee EO
    Life Sci; 2018 Sep; 209():259-266. PubMed ID: 30107166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells.
    Lin F; Huang CM; Cao J; Pei ZH; Gu WL; Fan SF; Li KP; Lin CM
    Genet Mol Res; 2015 Nov; 14(4):14440-7. PubMed ID: 26600502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.
    Gu T; Ohashi R; Cui R; Tajima K; Yoshioka M; Iwakami S; Sasaki S; Shinohara A; Matsukawa T; Kobayashi J; Inaba Y; Takahashi K
    Lung Cancer; 2009 Nov; 66(2):176-83. PubMed ID: 19285749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.
    Xue TC; Zou JH; Chen RX; Cui JF; Tang ZY; Ye SL
    Int J Oncol; 2014 Nov; 45(5):1883-90. PubMed ID: 25176314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
    Qin J; Luo M; Qian H; Chen W
    Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
    Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
    Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression.
    Chen RX; Xia YH; Xue TC; Ye SL
    J Exp Clin Cancer Res; 2010 Dec; 29(1):172. PubMed ID: 21190594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway.
    An J; Wang X; Guo P; Zhong Y; Zhang X; Yu Z
    Toxicol Lett; 2014 Aug; 229(1):265-72. PubMed ID: 24960055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.